Harish Dureja
Harish Dureja
Professor, Deptt of Pharm. Sci., M. D. University, Rohtak
Verified email at mdu.ac.in
Title
Cited by
Cited by
Year
Mouth dissolving tablets: A review
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41 (4), 187-193, 2004
2202004
Cosmeceuticals: An emerging concept
H Dureja, D Kaushik, M Gupta, V Kumar, V Lather
Indian Journal of Pharmacology 37 (3), 155, 2005
1382005
A novel pH-and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables
VK Gupta, MW Assmus, TE Beckert, JC Price
International journal of pharmaceutics 213 (1-2), 93-102, 2001
1132001
Simulation of Skin Permeability in Chitosan Membranes
Dureja Harish, Tiwary A. K. and Gupta Sunil
International Journal of Pharmaceutics 213, 193-198, 2001
1102001
Developments in nutraceuticals
H Dureja, D Kaushik, V Kumar
Indian journal of pharmacology 35 (6), 363-372, 2003
1002003
Predicting anti-HIV-1 activity of 6-arylbenzonitriles: Computational approach using superaugmented eccentric connectivity topochemical indices
H Dureja, S Gupta, AK Madan
Journal of Molecular Graphics and Modelling 26 (6), 1020-1029, 2008
952008
Superaugmented eccentric connectivity indices: new-generation highly discriminating topological descriptors for QSAR/QSPR modeling
H Dureja, AK Madan
Medicinal Chemistry Research 16 (7-9), 331-341, 2007
902007
Formulation and evaluation of olanzapine mouth dissolving tablets by effervescent formulation approach
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41, 410-412, 2004
652004
Orally disintegrating tablets: An overview of melt-in mouth tablet technologies and techniques
D Kaushik, H Dureja, TR Saini
Tablets capsules 2 (1), 30-6, 2004
652004
Topochemical models for prediction of cyclin-dependent kinase 2 inhibitory activity of indole-2-ones
H Dureja, AK Madan
Journal of Molecular Modeling 11 (6), 525-531, 2005
642005
Topological models for prediction of pharmacokinetic parameters of cephalosporins using random forest, decision tree and moving average analysis
H DUREJA, S GUPTA, AK MADAN
Scientia Pharmaceutica 76 (3), 377-394, 2008
442008
Nanoparticle technology for the delivery of poorly water-soluble drugs
V Kharb, M Bhatia, H Dureja, D Kaushik
Pharmaceutical technology (2003) 30 (2), 2006
432006
Formulation development and evaluation of alginate microspheres of ibuprofen
M Nagpal, DK Maheshwari, P Rakha, H Dureja, S Goyal, G Dhingra
Journal of Young Pharmacists 4 (1), 13-16, 2012
402012
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases
M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ...
Chemico-biological interactions 304, 10-19, 2019
382019
Prediction of h5-HT2A receptor antagonistic activity of arylindoles: computational approach using topochemical descriptors
H Dureja, AK Madan
Journal of Molecular Graphics and Modelling 25 (3), 373-379, 2006
342006
Recent patents and patented technology platforms for pharmaceutical taste masking
D Kaushik, H Dureja
Recent Patents on Drug Delivery & Formulation 8 (1), 37-45, 2014
332014
What is computational toxicology?
B Reisfeld, AN Mayeno
Computational Toxicology, 3-7, 2012
322012
Topochemical models for the prediction of permeability through blood–brain barrier
H Dureja, AK Madan
International journal of pharmaceutics 323 (1-2), 27-33, 2006
312006
Topochemical models for the prediction of lipophilicity of 1, 3-disubstituted propan-2-one analogs
H Dureja, V Kumar, S Gupta, AK Madan
Journal of Theoretical and Computational Chemistry 6 (03), 435-448, 2007
302007
Therapies in cancer treatment: An overview
M Gupta, J Dahiya, RK Marwaha, H Dureja
Int J Pharm Pharm Sci 7 (4), 1-9, 2015
272015
The system can't perform the operation now. Try again later.
Articles 1–20